Deadlock ransomware targeted Takis srl, an Italian biotechnology company focused on contract research and development of genetic vaccines and therapeutic antibodies. The attack compromised the company’s systems and data, resulting in disruption and data theft risks. #Italy
Incident Details
Information
- Takis Biotech is an Italian biotechnology company founded in 2009 and headquartered in Rome.
- The company specializes in contract research (R&D services), preclinical immunology, and the development of genetic vaccines and therapeutic antibodies.
Disclaimer: This post is based on public claims made by the ransomware group "Deadlock". I cannot confirm the accuracy of the information. However, I would be happy to share any official statement from the affected organization to provide clarification.